Ischemic Stroke Pathophysiology: Core, Penumbra and Perfusion

By Sachi Lord, CRNA Last updated October 26, 2026

Watch on YouTube Get the ICP and cerebral perfusion quick reference

What happens to brain tissue during an ischemic stroke?

Ischemic stroke reduces blood delivery enough to threaten neuronal energy production and ion balance. Function sometimes fails while tissue remains viable. The core represents more established severe injury, while the penumbra is threatened tissue with potential for rescue in suitable circumstances. Imaging estimates, collateral flow, timing and the clinical assessment guide interpretation.

Key takeaways

Ischemia and infarction describe different degrees of injury. A deficit does not count dead neurons.
An early CT without hemorrhage does not rule out ischemic stroke.
Last known well differs from the time symptoms are first discovered.
Collateral anatomy and a familiar blood pressure do not guarantee adequate regional flow.

In this video

How does reduced perfusion interfere with a neuron?

Neuronal signaling depends on ion gradients across the cell membrane. The sodium-potassium pump uses ATP to maintain these gradients over time. Reduced blood flow threatens metabolic support, ATP availability and ion homeostasis. Abnormal calcium accumulation, excitatory signaling, membrane injury and inflammation contribute to the evolving injury.

Function therefore sometimes fails before injury is irreversible. A weak arm or language deficit does not establish that every affected neuron is already dead. Threatened tissue remains at risk, so potential viability is a reason for urgent recognition rather than waiting to see whether symptoms persist.

How do the ischemic core and penumbra differ?

The ischemic core describes tissue judged to have more established severe injury. The penumbra is metabolically threatened tissue with remaining viability and risk of infarction if inadequate perfusion continues. Restoring suitable flow in eligible patients preserves some threatened tissue, without guaranteeing full recovery.

These are evolving physiological concepts estimated through clinical imaging. A boundary on a scan is not a perfect cell-by-cell map. Severity and duration of flow loss, collateral supply and metabolic conditions vary, so one fixed countdown does not determine when every affected cell becomes irreversibly injured.

Why do collateral circulation and autoregulation not guarantee protection?

Collateral vessels provide alternative routes, but the flow actually delivered depends on vessel anatomy, disease and pressure relationships. The circle of Willis connects major circulations without guaranteeing enough flow beyond an occlusion. A complete diagram of the circle is not proof of adequate collateral perfusion.

Autoregulation describes vascular resistance adjustments that help regulate cerebral blood flow. Disease and ischemia change that behavior. A textbook plateau is not every patient’s safe pressure range. Cerebral steal and luxury perfusion also describe different processes, and neither provides a routine hyperventilation prescription for ischemic stroke.

What do the exam, glucose and initial CT each establish?

The neurologic examination describes deficits and change over time. Glucose testing assesses hypoglycemia as a competing or coexisting cause. Initial brain imaging evaluates hemorrhage and tissue findings. No hemorrhage on an early CT does not exclude ischemia, because early ischemic changes are sometimes subtle or absent.

Vascular imaging assesses narrowing or occlusion. Selected advanced imaging adds information about tissue injury and potential viability. The 2026 AHA/ASA guideline includes options for selected unknown-onset and other patient groups. A simplified video does not determine thrombolysis or thrombectomy eligibility, and urgent evaluation should not await every possible test.

How should you communicate last known well?

Last known well is the last confirmed time the patient was at their baseline before the current symptoms. It is not automatically the time someone noticed the deficit. State the confirmed baseline, discovery time and any uncertainty separately rather than selecting a convenient onset time.

In the recording’s fictional example, baseline is confirmed at 9:10 and symptoms are discovered at 10:05. These observations leave the exact onset uncertain. The elapsed-time calculation is not a treatment decision or a safe delay. New deficits, unknown onset or improving symptoms still warrant urgent stroke assessment.

Sources

Related guides

Frequently Asked Questions

Does no hemorrhage on CT mean no stroke?

An initial CT without hemorrhage answers the bleeding question. It does not exclude ischemia or determine the amount of threatened viable tissue. Persistent focal deficits still require urgent clinical assessment and appropriate imaging.

Does weakness prove the affected brain cells are dead?

Neurologic function sometimes fails while some tissue remains viable. The deficit does not independently measure infarct size or salvageability. Potentially reversible dysfunction is one reason rapid evaluation and appropriate reperfusion selection matter.

Is last known well the time someone finds the patient?

Last known well is the last confirmed baseline before symptoms. Discovery time is when the problem was noticed. They sometimes differ substantially. Communicate both and preserve uncertainty about actual onset.

Does an unknown onset mean nothing can be done?

Unknown onset does not remove the need for urgent assessment. Current stroke guidance includes treatment options for selected patients using additional clinical and imaging criteria. A video or elapsed time alone does not establish eligibility.

Is hyperventilation a routine way to redirect blood to the penumbra?

The inverse-steal concept does not justify routine hyperventilation for every ischemic stroke. Carbon dioxide changes alter cerebral vessels, but the effect depends on the patient and disease. Physiological reasoning alone does not establish a ventilation treatment plan.